Hemming Johansson

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2024;46(10):2422-2431
Prognostic value of bone marrow and tumor ¹⁸F-FDG uptake on PET/CT in patients with oropharyngeal cancer and the interplay between inflammation and FDG uptake
Christou CN; Sandstrom K; Regula N; Ehrsson YT; Johansson H; Sorensen J; Laurell G
Article: BREAST CANCER RESEARCH AND TREATMENT. 2024;204(2):299-308
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
Zhu Y; Zerdes I; Matikas A; Cruz IR; Bergqvist M; Elinder E; Bosch A; Lindman H; Einbeigi Z; Andersson A; Carlsson L; Dreifaldt AC; Isaksson-Friman E; Hellstrom M; Johansson H; Wang K; Bergh JCS; Hatschek T; Foukakis T
Article: ACTA ONCOLOGICA. 2023;62(12):1592-1598
Comparison between Swedish EORTC QLQ-C30 general population norm data published in 2000 and 2019
Johansson H; Lagergren P; Nolte S; Brandberg Y
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2023;102(12):1653-1660
Incidence of and survival after surgical intervention for bowel obstruction in women with advanced ovarian cancer
Palsdottir K; Salehi S; Johansson H; Groes-Kofoed N; Falconer H; Joneborg U
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;111(5):748-756
Incidence of cardiovascular and bleeding events and reasons for discontinuation in patients with chronic lymphocytic leukemia treated with ibrutinib-A retrospective analysis on consecutive patients from a well-defined region
Andersson ML; Johansson H; Osterborg A; Mansson-Broberg A; Hansson L; Palma M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;111(5):715-721
Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients
Mattsson A; Sylvan SE; Axelsson P; Ellin F; Kjellander C; Larsson K; Lauri B; Lewerin C; Scharenberg C; Tatting L; Johansson H; Osterborg A; Hansson L
Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2023;63:102285
OptiBra study, a randomized controlled trial on optimal postoperative bra support after breast cancer surgery
Backman M; Hassan-Nur M; Fridblom K; Johansson H; Fredholm H; Fredriksson I
Article: CANCER. 2023;129(6):946-955
Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study
Omran M; Johansson H; Lundgren C; Silander G; Stenmark-Askmalm M; Loman N; Baan A; Adra J; Kuchinskaya E; Blomqvist L; Tham E; Bajalica-Lagercrantz S; Brandberg Y
Article: GYNECOLOGIC ONCOLOGY. 2023;170:259-265
Survival and chance of reversal after intestinal stoma formation during cytoreductive surgery for advanced ovarian cancer; a population-based cohort study
Kofoed NG; Falconer H; Vanky H; Johansson H; Abraham-Nordling M; Salehi S
Article: JOURNAL OF PLASTIC SURGERY AND HAND SURGERY. 2023;57(1-6):145-152
Clinical assessment of breast symmetry and aesthetic outcome: can 3D imaging be the gold standard?
Bai L; Lundstrom O; Johansson H; Meybodi F; Arver B; Sandelin K; Wickman M; Brandberg Y
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(4):3838
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma
Sandstrom K; Ehrsson YT; Sellberg F; Johansson H; Laurell G
Article: CLINICAL CANCER RESEARCH. 2023;29(3):532-540
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Gryback P; Bjohle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellstrom M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Article: ACTA ONCOLOGICA. 2022;61(10):1179-1185
High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation
Hjalm-Eriksson M; Ullen A; Nilsson S; Johansson H; Nilsson J; Castellanos E; Brandberg Y
Article: JAMA NETWORK OPEN. 2022;5(9):e2231583
Effectiveness of Single vs Multiple Doses of Prophylactic Intravenous Antibiotics in Implant-Based Breast Reconstruction A Randomized Clinical Trial
Gahm J; Konstantinidou AL; Lagergren J; Sandelin K; Glimaker M; Johansson H; Wickman M; de Boniface J; Frisell J
Article: CANCERS. 2022;14(4):1040
Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
Naeser Y; Helgadottir H; Hansson J; Ingvar C; Elander NO; Flygare P; Nilsson C; Jakobsson F; Valachis A; Papantoniou D; Nordin Danfors A; Johansson H; Sundin A; Brandberg Y; Ullenhag GJ
Article: LEUKEMIA. 2022;36(2):476-481
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients
Blixt L; Bogdanovic G; Buggert M; Gao Y; Hober S; Healy K; Johansson H; Kjellander C; Mravinacova S; Muschiol S; Nilsson P; Palma M; Pin E; Smith CIE; Stromberg O; Chen MS; Zain R; Hansson L; Osterborg A
Article: ACTA ONCOLOGICA. 2022;61(1):14-21
A biomarker panel predicts recurrence-free survival in ulcerated primary cutaneous melanoma
Falkenius J; Keskitalo J; Kanter L; Johansson H; Hoiom V; Hansson J; Brage SE
Article: ACTA OTO-LARYNGOLOGICA. 2022;142(1):78-83
Mandibular resection in patients with head and neck cancer: acute and long-term complications after reconstruction
Sjostrom M; Danielsson D; Munck-Wikland E; Nyberg J; Sandstrom K; Thor A; Johansson H; Ceghafi P; Udd SD; Emanuelsson J; Pettersson LF; Halle M; Laurell G
Article: BJS OPEN. 2021;5(6):zrab137
Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial
Erlandsson J; Fuentes S; Radu C; Frodin J-E; Johansson H; Brandberg Y; Holm T; Glimelius B; Martling A
Article: ACTA ONCOLOGICA. 2021;60(11):1513-1519
Surgery performed later in the week is associated with inferior survival in advanced ovarian cancer
Groes-Kofoed N; Hasselgren E; Bjorne H; Johansson H; Falconer H; Salehi S
Article: ACTA ONCOLOGICA. 2021;60(10):1301-1307
High rate of local control and cure at 10 years after treatment of prostate cancer with external beam radiotherapy and high-dose-rate brachytherapy: a single centre experience
Hjalm-Eriksson M; Nilsson S; Brandberg Y; Johansson H; Lennernas B; Lundell G; Castellanos E; Ullen A
Article: JAMA NETWORK OPEN. 2021;4(10):e2127806
Effect of Immediate Implant-Based Breast Reconstruction After Mastectomy With and Without Acellular Dermal Matrix Among Women With Breast Cancer A Randomized Clinical Trial
Lohmander F; Lagergren J; Johansson H; Roy PG; Brandberg Y; Frisell J
Article: JAMA ONCOLOGY. 2021;7(9):1360-1367
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer A Phase 2 Randomized Clinical Trial
Hatschek T; Foukakis T; Bjohle J; Lekberg T; Fredholm H; Elinder E; Bosch A; Pekar G; Lindman H; Schiza A; Einbeigi Z; Adra J; Andersson A; Carlsson L; Dreifaldt AC; Isaksson-Friman E; Agartz S; Azavedo E; Gryback P; Hellstrom M; Johansson H; Maes C; Zerdes I; Hartman J; Brandberg Y; Bergh J
Article: PLASTIC AND RECONSTRUCTIVE SURGERY - GLOBAL OPEN. 2021;9(5):e3561
Patient-reported Outcomes and 3-dimensional Surface Imaging after Risk-reducing Mastectomy and Immediate Breast Reconstruction
Bai L; Sandelin K; Wickman M; Arver B; Lundstrom O; Johansson H; Brandberg Y
Article: EJSO. 2021;47(2):353-359
Time-interval to adjuvant chemotherapy and postoperative management after upper abdominal surgical procedures in advanced ovarian cancer
Joneborg U; Palsdottir K; Farm E; Johansson H; Salehi S
Article: BJS OPEN. 2020;4(5):811-820
Quality of life and patient satisfaction after implant-based breast reconstruction with or without acellular dermal matrix: randomized clinical trial
Lohmander F; Lagergren J; Johansson H; Roy PG; Frisell J; Brandberg Y
Article: LEUKEMIA & LYMPHOMA. 2020;61(9):2136-2144
A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapy
Asklid A; Sylvan SE; Mattsson A; Winqvist M; Johansson H; Osterborg A; Hansson L
Article: ACTA ONCOLOGICA. 2020;59(7):760-765
Surgery performed later in the week is associated with failure to achieve complete radical surgical resection in advanced ovarian cancer
Palsdottir K; Joneborg U; Hasselgren E; Johansson H; Salehi S
Article: CANCER. 2020;126(6):1175-1182
Efficacy and Safety of Tailored and Dose-Dense Adjuvant Chemotherapy and Trastuzumab for Resected HER2-Positive Breast Cancer: Results From the Phase 3 PANTHER Trial
Papakonstantinou A; Matikas A; Bengtsson NO; Malmstrom P; Hedayati E; Steger G; Untch M; Hubbert L; Johansson H; Hellstrom M; Gnant M; Loibl S; Greil R; Moebus V; Foukakis T; Bergh J
Article: EUROPEAN JOURNAL OF CANCER. 2020;127:173-182
Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)
Holmsten K; Jensen NV; Mouritsen LS; Jonsson E; Mellnert C; Agerbaek M; Nilsson C; Moe M; Carus A; Ofverholm E; Lahdenpera O; Brandberg Y; Johansson H; Hellstrom M; von der Maase H; Pappot H; Ullen A
Article: JOURNAL OF CLINICAL NURSING. 2019;28(17-18):3262-3270
Improved patient satisfaction 2 years after introducing person-centred handover in an oncological inpatient care setting
Kullberg A; Sharp L; Johansson H; Brandberg Y; Bergenmar M
Article: ACTA RADIOLOGICA. 2019;60(8):955-961
An audit of performance, interpretation, and influence of pretherapeutic MRI in rectal cancer: a Swedish population-based cohort study
Elliot AH; Blomqvist L; Sigurdsson A; Martling A; Johansson H; Glimelius B; Nilsson PJ
Article: ANNALS OF SURGERY. 2019;269(5):836-841
Implant Based Breast Reconstruction With Acellular Dermal Matrix Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast Cancer Treatment
Lohmander F; Lagergren J; Roy PG; Johansson H; Brandberg Y; Eriksen C; Frisell J
Article: ANNALS OF ONCOLOGY. 2019;30(4):604-611
Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment
Weibring K; Nord C; Stahl O; Eberhard J; Sandberg K; Johansson H; Arver S; Giwercman A; Cohn-Cedermark G
Article: BREAST. 2019;44:120-127
Body image problems in women with and without breast cancer 6-20 years after bilateral risk-reducing surgery - A prospective follow-up study
Bai L; Arver B; Johansson H; Sandelin K; Wickman M; Brandberg Y
Article: HAEMATOLOGICA. 2019;104(4):797-804
FFirst-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013
Sylvan SE; Asklid A; Johansson H; Klintman J; Bjellvi J; Tolvgard S; Kimby E; Norin S; Andersson P-O; Karlsson C; Karlsson K; Lauri B; Mattsson M; Sandstedt AB; Strandberg M; Osterborg A; Hansson L
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019;29(1):86-93
Lymphedema, serious adverse events, and imaging 1 year after comprehensive staging for endometrial cancer: results from the RASHEC trial
Salehi S; Avall-Lundqvist E; Brandberg Y; Johansson H; Suzuki C; Falconer H
Article: ANNALS OF ONCOLOGY. 2019;30(1):109-114
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients
Matikas A; Foukakis T; Moebus V; Greil R; Bengtsson N-O; Steger GG; Untch M; Johansson H; Hellstrom M; Malmstrom P; Gnant M; Loibl S; Bergh J
Article: ACTA ONCOLOGICA. 2018;57(12):1671-1676
Long-term quality of life after comprehensive surgical staging of high-risk endometrial cancer - results from the RASHEC trial
Salehi S; Brandberg Y; Avall-Lundqvist E; Suzuki C; Johansson H; Legerstam B; Falconer H
Article: ACTA OTO-LARYNGOLOGICA. 2018;138(12):1123-1127
Trismus in patients with head and neck cancer and 5-year overall survival
Astradsson T; Laurell G; Ahlberg A; Nikolaidis P; Johansson H; Ehrsson YT
Article: EUROPEAN JOURNAL OF CANCER. 2018;97:33-40
Weekly versus 3-weekly cabazitaxel for the treatment of castration-resistant prostate cancer: A randomised phase II trial (ConCab)
Yachnin J; Gilje B; Thon K; Johansson H; Brandberg Y; Panaretakis T; Ullen A
Article: COLORECTAL DISEASE. 2018;20(5):399-406
Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions
Iversen H; Martling A; Johansson H; Nilsson PJ; Holm T
Article: MOLECULAR AND CLINICAL ONCOLOGY. 2018;8(1):141-146
Effect on prostate volume following neoadjuvant treatment with an androgen receptor inhibitor monotherapy versus castration plus an androgen receptor inhibitor in prostate cancer patients intended for curative radiation therapy: A randomised study
Majumder K; Brandberg Y; Johansson H; Castellanos E; Ullen A; Lennernas B; Nilsson S
Article: EJSO. 2018;44(1):100-107
Management and prognosis of locally recurrent rectal cancer - A national population-based study
Westberg K; Palmer G; Hjern F; Johansson H; Holm T; Martling A
Article: BJS-BRITISH JOURNAL OF SURGERY. 2017;104(13):1866-1873
Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer
Westberg K; Palmer G; Hjern F; Nordenvall C; Johansson H; Holm T; Martling A
Article: BMC CANCER. 2017;17(1):584
Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma
Falkenius J; Johansson H; Tuominen R; Stolt MF; Hansson J; Brage SE
Article: BMC CANCER. 2017;17(1):379
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
de Boniface J; Frisell J; Andersson Y; Bergkvist L; Ahlgren J; Ryden L; Bagge RO; Sund M; Johansson H; Lundstedt D
Article: PLOS ONE. 2017;12(4):e0175397
Patient satisfaction after implementation of person-centred handover in oncological inpatient care - A cross-sectional study
Kullberg A; Sharp L; Johansson H; Brandberg Y; Bergenmar M
Article: LANCET ONCOLOGY. 2017;18(3):336-346
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
Erlandsson J; Holm T; Pettersson D; Berglund A; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallbook O; Syk I; Glimelius B; Martling A
Article: GLAND SURGERY. 2017;6(1):64-72
Preoperative psychosocial characteristics may predict body image and sexuality two years after risk-reducing mastectomy: a prospective study
Unukovych D; Johansson H; Brandberg Y
Article: ACTA ONCOLOGICA. 2017;56(1):21-26
Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts
Hjalm-Eriksson M; Ullen A; Johansson H; Levitt S; Nilsson S; Kalkner K-M
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2016;316(18):1888-1896
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer A Randomized Clinical Trial
Foukakis T; von Minckwitz G; Bengtsson N-O; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellstrom M; Johansson H; Anderson H; Malmstrom P; Gnant M; Greil R; Mobus V; Bergh J
Article: EJSO. 2016;42(11):1667-1673
Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer
Elliot AH; Martling A; Glimelius B; Johansson H; Nilsson PJ
Article: EUROPEAN JOURNAL OF CANCER. 2016;65:43-51
Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study
Majumder K; Nilsson S; Johansson H; Ullen A; Lennernas B; Bergenmar M; Brandberg Y
Article: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2016;2:6-11
Patients' knowledge and perceived understanding - Associations with consenting to participate in cancer clinical trials
Brandberg Y; Johansson H; Bergenmar M
Article: INTERNATIONAL JOURNAL OF BREAST CANCER. 2016;2016:4604852-7
Associations between Reoperations and Psychological Factors after Contralateral Risk-Reducing Mastectomy: A Two-Year Follow-Up Study
Unukovych D; Wickman M; Sandelin K; Arver B; Johansson H; Brandberg Y
Article: COLORECTAL DISEASE. 2016;18(1):73-79
Accuracy of preoperative T and N staging in colon cancer - a national population-based study
Sjovall A; Blomqvist L; Egenvall M; Johansson H; Martling A
Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2015;19(6):724-730
Nurse-led outpatient clinics in oncology care - Patient satisfaction, information and continuity of care
Berglund CB; Gustafsson E; Johansson H; Bergenmar M
Article: EJSO. 2015;41(5):659-666
Time to local recurrence as a prognostic factor in patients with rectal cancer
Westberg K; Palmer G; Johansson H; Holm T; Martling A
Article: EJSO. 2015;41(4):577-584
Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery
Sackey H; Johansson H; Sandelin K; Liljegren G; MacLean G; Frisell J; Brandberg Y
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2015;46(1):381-388
Long-term health-related quality of life after curative treatment for prostate cancer: A regional cross-sectional comparison of two standard treatment modalities
Hjalm-Eriksson M; Lennernas B; Ullen A; Johansson H; Hugosson J; Nilsson S; Brandberg Y
Article: EJSO. 2014;40(12):1782-1788
Preoperative treatment selection in rectal cancer: A population-based cohort study
Elliot AH; Martling A; Glimelius B; Nordenvall C; Johansson H; Nilsson PJ
Article: LEUKEMIA & LYMPHOMA. 2014;55(12):2769-2777
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic
Mulligan SP; Karlsson K; Stromberg M; Jonsson V; Gill D; Hammerstrom J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundstrom G; Johansson H; Brandberg Y; Liliemark J; Juliusson G
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(8):1389-1394
Metabolic Markers and HSP60 in Chemonaive Serous Solid Ovarian Cancer Versus Ascites
Hjerpe E; Brage SE; Stolt MF; Johansson H; Shoshan M; Avall-Lundqvist E
Article: ACTA ONCOLOGICA. 2014;53(9):1197-1204
Audio-recorded information to patients considering participation in cancer clinical trials - a randomized study
Bergenmar M; Johansson H; Wilking N; Hatschek T; Brandberg Y
Article: BREAST. 2014;23(4):357-363
Physical therapy after prophylactic mastectomy with breast reconstruction: A prospective randomized study
Unukovych D; Johansson H; Johansson E; Arver B; Liljegren A; Brandberg Y
Article: CLINICAL GENITOURINARY CANCER. 2014;12(3):e71-e82
Less Satisfaction With Information in Patients With Prostate Cancer Treated With Surgery and Salvage Radiotherapy Compared With Patients Treated With Curative Radiotherapy Alone, Despite Similar Health-Related Quality of Life
Majumder K; Brandberg Y; Johansson H; Nilsson S; Bergenmar M
Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2014;18(3):305-309
Patients' perception of information after completion of adjuvant radiotherapy for breast cancer
Bergenmar M; Johansson H; Sharp L
Article: BJS-BRITISH JOURNAL OF SURGERY. 2014;101(4):371-382
Phase III development of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire module for women undergoing breast reconstruction.
Winters ZE; Balta V; Thomson HJ; Brandberg Y; Oberguggenberger A; Sinove Y; Unukovych D; Nava M; Sandelin K; Johansson H; European Organization for Research and Treatment o; Dobbeleir J; Blondeel P; Bruno N; Catanuto G; Llewellyn-Bennett R
Article: RADIATION ONCOLOGY. 2014;9:14
No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction.
Liljegren A; Unukovych D; Gagliardi G; Bjöhle J; Wickman M; Johansson H; Sandelin K
Article: MELANOMA RESEARCH. 2013;23(6):452-460
High expression of glycolytic and pigment proteins is associated with worse clinical outcome in stage III melanoma
Falkenius J; Lundeberg J; Johansson H; Tuominen R; Frostvik-Stolt M; Hansson J; Brage SE
Article: BMC CLINICAL PATHOLOGY. 2013;13(1):30
Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer
Hjerpe E; Brage SE; Carlson J; Stolt MF; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
Article: BREAST. 2013;22(5):634-638
Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer
Sharp L; Johansson H; Hatschek T; Bergenmar M
Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2013;17(4):429-435
No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions - Results from a randomised blinded trial
Sharp L; Finnila K; Johansson H; Abrahamsson M; Hatschek T; Bergenmar M
Article: ACTA ONCOLOGICA. 2013;52(6):1086-1093
Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma
Brandberg Y; Johansson H; Aamdal S; Bastholt L; Hernberg M; Stierner U; von der Maase H; Hansson J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2013;139(3):751-758
Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial
Bjohle J; Bergqvist J; Gronowitz JS; Johansson H; Carlsson L; Einbeigi Z; Linderholm B; Loman N; Malmberg M; Soderberg M; Sundquist M; Walz TM; Ferno M; Bergh J; Hatschek T
Article: BJS-BRITISH JOURNAL OF SURGERY. 2013;100(7):969-975
Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial
Pettersson D; Glimelius B; Iversen H; Johansson H; Holm T; Martling A
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2013;23(3):448-455
HSP60 Predicts Survival in Advanced Serous Ovarian Cancer
Hjerpe E; Egyhazi S; Carlson J; Stolt MF; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
Article: EUROPEAN JOURNAL OF CANCER. 2013;49(1):52-59
Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial
Fahlen M; Fornander T; Johansson H; Johansson U; Rutqvist L-E; Wilking N; von Schoultz E
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2013;23(1):41-51
Prognostic Significance of Cell Cycle- and Invasion-Related Molecular Markers and Genomic Instability in Primary Carcinoma of the Vagina
Hellman K; Johansson H; Andersson S; Pettersson F; Auer G
Article: EUROPEAN JOURNAL OF CANCER. 2012;48(17):3150-3156
Contralateral prophylactic mastectomy in breast cancer patients with a family history: a prospective 2-years follow-up study of health related quality of life, sexuality and body image.
Unukovych D; Sandelin K; Liljegren A; Arver B; Wickman M; Johansson H; Brandberg Y
Article: BREAST CANCER RESEARCH AND TREATMENT. 2012;135(3):791-798
Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial
Liljegren A; Gunnarsson P; Landgren B-M; Robeus N; Johansson H; Rotstein S
Article: ACTA ONCOLOGICA. 2012;51(7):934-941
Breast reconstruction in patients with personal and family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year experience
Unukovych D; Sandelin K; Wickman M; Arver B; Johansson H; Brandberg Y; Liljegren A
Article: MEDICAL ONCOLOGY. 2012;29(2):432-438
Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer
Svensson H; Hatschek T; Johansson H; Einbeigi Z; Brandberg Y
Article: EUROPEAN JOURNAL OF CANCER. 2012;48(6):813-819
Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study
Braendengen M; Tveit KM; Hjermstad MJ; Johansson H; Berglund A; Brandberg Y; Glimelius B
Article: FAMILIAL CANCER. 2012;11(1):33-40
Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer
Stahlbom AK; Johansson H; Liljegren A; von Wachenfeldt A; Arver B
Article: EJSO. 2012;38(1):38-43
Less correspondence between expectations before and cosmetic results after risk-reducing mastectomy in women who are mutation carriers: A prospective study
Brandberg Y; Arver B; Johansson H; Wickman M; Sandelin K; Liljegren A
Article: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2012;34(1):66-72
MORBIDITY OF SUPRAOMOHYOIDAL AND MODIFIED RADICAL NECK DISSECTION COMBINED WITH RADIOTHERAPY FOR HEAD AND NECK CANCER. A PROSPECTIVE LONGITUDINAL STUDY
Ahlberg A; Nikolaidis P; Engstrom T; Gunnarsson K; Johansson H; Sharp L; Laurell G
Article: EUROPEAN JOURNAL OF CANCER. 2011;47(18):2665-2672
Frequency and severity of skin reactions in patients with breast cancer undergoing adjuvant radiotherapy, the usefulness of two assessment instruments - A pilot study
Sharp L; Johansson H; Landin Y; Moegelin I-M; Bergenmar M
Article: BREAST CANCER RESEARCH AND TREATMENT. 2011;128(3):755-763
Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer
Sverrisdottir A; Johansson H; Johansson U; Bergh J; Rotstein S; Rutqvist L; Fornander T
Article: ACTA OTO-LARYNGOLOGICA. 2011;131(5):552-561
Early self-care rehabilitation of head and neck cancer patients
Ahlberg A; Engstrom T; Nikolaidis P; Gunnarsson K; Johansson H; Sharp L; Laurell G
Article: CLINICAL TRIALS. 2011;8(1):77-84
Levels of knowledge and perceived understanding among participants in cancer clinical trials - factors related to the informed consent procedure
Bergenmar M; Johansson H; Wilking N
Article: BREAST CANCER RESEARCH AND TREATMENT. 2011;125(2):553-561
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
Wilking U; Karlsson E; Skoog L; Hatschek T; Lidbrink E; Elmberger G; Johansson H; Lindstrom L; Bergh J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2009;117(3):561-567
Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
Sverrisdottir A; Nystedt M; Johansson H; Fornander T
Article: ACTA ONCOLOGICA. 2009;48(1):86-92
Socioeconomic status and quality of life of women with family history of breast cancer attending an oncogenetic counseling clinic - a comparison with general population
Von Wachenfeldt A; Brandberg Y; Johansson H; Fornander T
Article: ACTA ONCOLOGICA. 2009;48(6):915-920
Cancer patients without a known primary: Incidence and survival trends in Sweden 1960-2007
Randen M; Rutqvist L-E; Johansson H
Article: EUROPEAN JOURNAL OF CANCER CARE. 2008;17(2):114-119
Smoking cessation among patients with head and neck cancer:: cancer as a 'teachable moment'
Sharp L; Johansson H; Fagerstrom K; Rutqvist LE
Article: ACTA ONCOLOGICA. 2008;47(6):1113-1121
Predicting distant dissemination in patients with early breast cancer
Arriagada R; Rutqvist L-E; Johansson H; Kramar A; Rotstein S
Article: BREAST CANCER RESEARCH AND TREATMENT. 2007;107(1):71-78
Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen
Khoshnoud MR; Fornander T; Johansson H; Rutqvist L-E
Article: ACTA ONCOLOGICA. 2007;46(1):90-96
Factors associated with return to work after breast cancer treatment
Johnsson A; Fornander T; Olsson M; Nystedt M; Johansson H; Rutqvist LE
Article: ACTA ONCOLOGICA. 2007;46(2):133-145
Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer
Rutqvist LE; Johansson H
Article: FAMILIAL CANCER. 2006;5(4):309-321
Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County
Margolin S; Johansson H; Rutqvist LE; Lindblom A; Fornander T
Article: ANTICANCER RESEARCH. 2006;26(6C):4753-4759
Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer
He Q; Fornander T; Johansson H; Johansson U; Hu GZ; Rutqvist L-E; Skog S
Article: ACTA ONCOLOGICA. 2006;45(5):517-527
Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients
Rutqvist LE; Johansson H
Article: BJS-BRITISH JOURNAL OF SURGERY. 2005;92(2):225-229
Impact of a surgical training programme on rectal cancer outcomes in Stockholm
Martling A; Holm T; Rutqvist LE; Johansson H; Moran BJ; Heald RJ; Cedermark B
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2005;61(1):250-256
Randomized trial on two types of thermoplastic masks for patient immobilization during radiation therapy for head-and-neck cancer
Sharp L; Lewin F; Johansson H; Payne D; Gerhardsson A; Rutqvist LE
Article: EJSO. 2004;30(6):602-609
A randomised study of axillary drainage and pectoral fascia preservation after mastectomy for breast cancer
Dalberg K; Johansson H; Signomklao T; Rutqvist LE; Bergkvist L; Frisell J; Liljegren G; Ambre T; Sandelin K
Article: BJS-BRITISH JOURNAL OF SURGERY. 2002;89(8):1008-1013
The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer
Martling A; Cedermark B; Johansson H; Rutqvist LE; Holm T
Article: ACTA ONCOLOGICA. 2002;41(2):138-146
Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994
Mansson-Brahme E; Johansson H; Larsson O; Rutqvist LE; Ringborg U
Article: CANCER. 2001;92(4):896-902
The Stockholm II trial on preoperative radiotherapy in rectal carcinoma - Long-term follow-up of a population-based study
Martling A; Holm T; Johansson H; Rutqvist LE; Cedermark R
Article: BJS-BRITISH JOURNAL OF SURGERY. 2001;88(6):839-843
Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer
Holm T; Johansson H; Rutqvist LE; Cedermark B
Article: CANCER. 2000;89(7):1495-1501
Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm
Cohn-Cedermark G; Rutqvist LE; Andersson R; Breivald M; Ingvar C; Johansson H; Jönsson PE; Krysander L; Lindholm C; Ringborg U
Article: LARYNGOSCOPE. 2000;110(9):1498-1504
A prospective population-based study of cutaneous malignant melanoma of the head and neck
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Article: LAKARTIDNINGEN. 2000;97(34):3582-3586
[Improved therapeutic results in rectal cancer. Preoperative radiotherapy and continuing education of the surgeons is efficient].
Holm T; Cedermark B; Johansson H; Singnomklao T; Rutqvist LE
Article: CANCER. 2000;89(2):348-355
Trends in mortality from malignant melanoma in Sweden, 1970-1996
Cohn-Cedermark G; Månsson-Brahme E; Rutqvist LE; Larsson O; Johansson H; Ringborg U
Article: EUROPEAN JOURNAL OF CANCER. 2000;36(11):1374-1380
The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen
Billgren AM; Rutqvist LE; Johansson H; Hägerström T; Skoog L
Article: ACTA ONCOLOGICA. 1999;38(8):1069-1074
Epidemiological characteristics of cutaneous malignant melanoma of the head and neck -: A population-based study
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Article: CANCER. 1998;82(11):2204-2211
A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery
Dalberg K; Johansson H; Johansson U; Rutqvist LE
Article: OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 1998;55(6):393-400
Occupational exposures and squamous cell carcinoma of the oral cavity, pharynx, larynx, and oesophagus: A case-control study in Sweden
Gustavsson P; Jakobsson R; Johansson H; Lewin F; Norell S; Rutkvist LE
Article: ACTA ONCOLOGICA. 1998;37(5):463-470
Central nervous system metastases of cutaneous malignant melanoma - A population-based study
Cohn-Cedermark G; Månsson-Brahme E; Rutqvist LE; Larsson O; Johansson H; Ringborg U
Article: LAKARTIDNINGEN. 1997;94(25):2391-2394
[Therapeutic results in rectal cancer surgery. Surgical technique is of great significance].
Holm T; Johansson H; Cedermark B; Rutqvist LE; Ekelund G
Article: BJS-BRITISH JOURNAL OF SURGERY. 1997;84(5):657-663
Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy
Holm T; Johansson H; Cedermark B; Ekelund G; Rutqvist LE
Article: BJS-BRITISH JOURNAL OF SURGERY. 1996;83(7):964-968
Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: Causes and risk factors
Holm T; Rutqvist LE; Johansson H; Cedermark B
Article: CANCER. 1996;77(9):1809-1814
Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm - A randomized study by the Swedish melanoma study group
Ringborg U; Andersson R; Eldh J; Glaumann B; Hafstrom L; Jacobsson S; Jonsson PE; Johansson H; Krysander L; Lagerlof B; Christer L; Bjorn N; CarlMagnus R; Erik RL; Gunnar W; Athlin L; Bergman O; Carlsson L; Cosmo P; Danielsson H; Eriksson M; Grenabo J; Gustavsson L; Haghjoo A; Holmner S; Hogman L; Ingvar C; Jansson K; Jaska F; Lindmark L; Moell PO; Mossberg I; Ohlsson E; Persson NA; Segerstrom A; Sellstrom H; Tholin B; Widman BG; Wiren M; Ohrn PG
Article: BJS-BRITISH JOURNAL OF SURGERY. 1995;82(9):1213-1216
ABDOMINOPERINEAL RESECTION AND ANTERIOR RESECTION IN THE TREATMENT OF RECTAL-CANCER - RESULTS IN RELATION TO ADJUVANT PREOPERATIVE RADIOTHERAPY
HOLM T; RUTQVIST LE; JOHANSSON H; CEDERMARK B
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 1995;87(9):645-651
ADJUVANT TAMOXIFEN THERAPY FOR EARLY-STAGE BREAST-CANCER AND 2ND PRIMARY MALIGNANCIES
RUTQVIST LE; JOHANSSON H; SIGNOMKLAO T; JOHANSSON U; FORNANDER T; WILKING N
Article: CANCER. 1995;75(9):2269-2275
THE STOCKHOLM-I TRIAL OF PREOPERATIVE SHORT-TERM RADIOTHERAPY IN OPERABLE RECTAL-CARCINOMA - A PROSPECTIVE RANDOMIZED TRIAL
CEDERMARK B; JOHANSSON H; RUTQVIST LE; WILKING N
Article: JOURNAL OF CLINICAL ONCOLOGY. 1995;13(2):430-434
INFLUENCE OF PRIOR AND SUBSEQUENT PREGNANCY ON BREAST-CANCER PROGNOSIS
VONSCHOULTZ E; JOHANSSON H; WILKING N; RUTQVIST LE
Visa fler

Alla övriga publikationer

Published conference paper: BREAST CANCER RESEARCH AND TREATMENT. 2018;168(2):349-355
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
Matikas A; Margolin S; Hellstrom M; Johansson H; Bengtsson N-O; Karlsson L; Edlund P; Karlsson P; Lidbrink E; Linderholm B; Lindman H; Malmstrom P; Villman K; Foukakis T; Bergh J
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2011;9(1):2-3
DIFFERENCE IN HORMONE-RECEPTOR STATUS OF BREAST CANCERS IN VIETNAMESE AND SWEDISH WOMEN
Vu T; Tani E; Johansson H; Adolfsson J; Krawiec K; Ta V; Skoog L
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2010;8(3):197
Quality of life in women with metastatic breast cancer during nine months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine)
Svensson H; Einbeigi Z; Johansson H; Hatschek T; Brandberg Y
Letter: CLINICAL ONCOLOGY. 2008;20(7):564
Cancer with unknown primary -: Implementation of a regional referral process and clinical practice guidelines
Randen M; Lewin F; Frankling MH; Johansson H; Lagerros C; Rutqvist LE
Published conference paper: CANCER. 1998;82(7):1367-1375
Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck - A population-based case-referent study in Sweden
Lewin F; Norell SE; Johansson H; Gustavsson P; Wennerberg J; Biörklund A; Rutqvist LE
Published conference paper: ANNALS OF SURGICAL ONCOLOGY. 1996;3(5):423-430
Randomized study on preoperative radiotherapy in rectal carcinoma
Cedermark B; Johansson H; Rutqvist LE; Wilking N; Broberg M; Johansson C; Goldman S; Akerud L; Brismar B; Ewerth S; Lundell G; Rubio C; Singnomklao T; Ost A; Svensson SO; Fenyo G; Eriksson L; Hellstrom B; Lindholmer C; Theve T; Dalen J; Magnusson I; Rieger A; Svensson C; Ohman U; Bark S; Sundblad M

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI